The automated head-to-toe shielding device, which reportedly blocks over 90 percent of radiation scatter to interventional radiologists and other clinicians, is now compatible with Siemens Artis fluoroscopy C-arm systems.
The Radiation Shielding System, an emerging system that reduces exposure to ionizing radiation associated with fluoroscopy C-arm devices, has garnered an expanded 510(k) clearance from the Food and Drug Administration (FDA), according to the manufacturer Radiaction Medical.
The company said the expanded FDA clearance covers compatibility of the Radiation Shielding System with Siemens Artis fluoroscopy C-arm systems. The system is also compatible with Toshiba Infinix-I devices (Canon Medical).
Radiaction Medical noted the Radiation Shielding System, which received initial FDA 510(k) clearance in March 2022, encapsulates the imaging beam of fluoroscopy C-arm systems, blocking scattered radiation at its source. One study showed that the Radiation Shielding System reduces radiation scatter by more than 90 percent during interventional procedures.1
“The reactions to our Shield System technology and capabilities have been extremely encouraging. Awareness has been growing about the negative implications of staff radiation exposure in interventional labs, but until now, there was no meaningful, comprehensive way to address the problem,” noted Jonathan Yifat, the CEO of Radiaction Medical.
Reference
1. Laish-Farkash A, Harari E, Finkelstein A, et al. A novel robotic radiation shielding device for interventional cardiology procedures. EuroIntervention. 2022;18:262-266.
Study: AI Bolsters Sensitivity for Pneumothorax on CXR and Significantly Reduces Reporting Time
October 30th 2024For clinically actionable pneumothorax, an artificial intelligence algorithm demonstrated a 93 percent AUC and a 96 percent specificity rate in a study involving chest X-rays from over 27,000 adults.
Comparative Study Evaluates AI Products for Detecting Tuberculosis on Chest X-Rays
August 9th 2024At a 90 percent threshold for sensitivity, Lunit’s Insight CXR and the Nexus CXR software from Nexus demonstrated the highest specificity rates for tuberculosis (TB) detection in a patient population with a high prevalence of TB and HIV.